Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 19.80M | $ 31.20M | $ 58.80M | $ 44.20M | $ 9.40M |
Total Assets | $ 838.90M | $ 791.20M | $ 509.10M | $ 383.60M | $ 240.70M |
Total Debt | $ 204.00M | $ 164.50M | $ 120.50M | $ 19.90M | $ 26.60M |
Net Debt | $ 184.20M | $ 133.30M | $ 61.70M | $ -24.30M | $ 17.20M |
Total Liabilities | $ 390.80M | $ 345.20M | $ 242.80M | $ 120.20M | $ 102.50M |
Stockholders Equity | $ 448.10M | $ 446.00M | $ 266.30M | $ 263.40M | $ 138.20M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |